The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), causing the 2019 novel coronavirus disease (COVID-19), was introduced by WHO (World Health Organization) as “pandemic” in March 2020. According to WHO, thus far (23 November 2020) 58,425,681 infected cases including 1,385,218 deaths have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi-kalbolandi, Shima, Majidzadeh-A, Keyvan, Abdolvahab, Mohadeseh Haji, Jalili, Neda, Farahmand, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996120/
https://www.ncbi.nlm.nih.gov/pubmed/33770348
http://dx.doi.org/10.1007/s12602-021-09773-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996120/
https://www.ncbi.nlm.nih.gov/pubmed/33770348
http://dx.doi.org/10.1007/s12602-021-09773-9

Ejemplares similares